awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33885999-5A4B2CEC-EB4E-4586-B304-384C95885BA2
Q33885999-5A4B2CEC-EB4E-4586-B304-384C95885BA2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33885999-5A4B2CEC-EB4E-4586-B304-384C95885BA2
Optimizing adherence to adjuvant imatinib in gastrointestinal stromal tumor.
P2860
Q33885999-5A4B2CEC-EB4E-4586-B304-384C95885BA2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33885999-5A4B2CEC-EB4E-4586-B304-384C95885BA2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
81cbf51c35c9ca7eec3f79400e662ae01506c20c
P2860
Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.